Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Brookfield Infrastructure
BIPC
$5.01B
| $9.78M | ﹤0.01% |
277,097
+49,061
| +22% | +$1.56M |
|
2002
Relay Therapeutics
RLAY
$4.37B
| $9.66M | ﹤0.01% |
877,813
+163,008
| +23% | +$1.38M |
|
2003
E.W. Scripps
SSP
$310M
| $9.61M | ﹤0.01% |
1,203,306
+210,673
| +21% | +$1.42M |
|
2004
Middlesex Water
MSEX
$1.11B
| $9.58M | ﹤0.01% |
146,041
+7,893
| +6% | +$520K |
|
2005
Malibu Boats
MBUU
$573M
| $9.58M | ﹤0.01% |
174,773
-10,588
| -6% | -$508K |
|
2006
Merchants Bancorp
MBIN
$2.54B
| $9.56M | ﹤0.01% |
224,580
+39,248
| +21% | +$1.29M |
|
2007
Phreesia
PHR
$780M
| $9.56M | ﹤0.01% |
412,763
+15,298
| +4% | +$264K |
|
2008
BioCryst Pharmaceuticals
BCRX
$2.51B
| $9.55M | ﹤0.01% |
1,594,436
+133,629
| +9% | +$774K |
|
|
CCRN
2009
DELISTED
Cross Country Healthcare
CCRN
| $9.54M | ﹤0.01% |
421,576
+19,689
| +5% | +$427K |
|
2010
Myers Industries
MYE
$1.25B
| $9.54M | ﹤0.01% |
487,725
+23,882
| +5% | +$425K |
|
2011
OneSpaWorld
OSW
$2.73B
| $9.53M | ﹤0.01% |
675,696
+9,496
| +1% | +$110K |
|
2012
Mercado Libre
MELI
$92.7B
| $9.45M | ﹤0.01% |
6,016
-249
| -4% | -$353K |
|
2013
Titan Machinery
TITN
$420M
| $9.44M | ﹤0.01% |
327,011
+28,719
| +10% | +$744K |
|
2014
Designer Brands
DBI
$312M
| $9.44M | ﹤0.01% |
1,066,172
-6,203
| -0.6% | -$65.3K |
|
2015
Dutch Bros
BROS
$8.93B
| $9.4M | ﹤0.01% |
296,939
+14,158
| +5% | +$386K |
|
2016
Collegium Pharmaceutical
COLL
$913M
| $9.4M | ﹤0.01% |
305,466
-4,673
| -2% | -$117K |
|
2017
PAR Technology
PAR
$770M
| $9.39M | ﹤0.01% |
215,699
+5,143
| +2% | +$193K |
|
2018
XPEL
XPEL
$1.39B
| $9.35M | ﹤0.01% |
173,637
+1,372
| +0.8% | +$73.7K |
|
2019
BrightView Holdings
BV
$1.08B
| $9.34M | ﹤0.01% |
1,109,150
+63,915
| +6% | +$487K |
|
2020
Winmark
WINA
$1.26B
| $9.33M | ﹤0.01% |
22,345
+238
| +1% | +$100K |
|
2021
Compass
COMP
$10.2B
| $9.33M | ﹤0.01% |
2,481,401
+63,082
| +3% | +$156K |
|
2022
Zumiez
ZUMZ
$319M
| $9.31M | ﹤0.01% |
457,780
+39,470
| +9% | +$707K |
|
2023
Janus International
JBI
$686M
| $9.28M | ﹤0.01% |
711,467
+18,354
| +3% | +$195K |
|
|
PKST
2024
DELISTED
Peakstone Realty Trust
PKST
| $9.28M | ﹤0.01% |
465,779
+10,449
| +2% | +$170K |
|
2025
Enact Holdings
ACT
$6.84B
| $9.26M | ﹤0.01% |
320,473
+31,603
| +11% | +$882K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.